KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

105 hedge funds and large institutions have $408M invested in KalVista Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 20 closing their positions.

Holders
105
Holders Change
-5
Holders Change %
-4.55%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
34
Reduced
33
Closed
20
Calls
$533K
Puts
$3.54M
Net Calls
-$3.01M
Net Calls Change
-$417K

Top Buyers

1
SCM
1
Suvretta Capital Management
New York
$26.9M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$20.7M
3
FM
3
Frazier Management
Washington
$2.74M
4
DCM
4
DAFNA Capital Management
California
$3.3M
5
MIM
5
Monashee Investment Management
Massachusetts
$2.18M

Top Sellers

1
NIP
1
Nicholas Investment Partners
California
$3.79M
2
State Street
2
State Street
Massachusetts
$18.2M
3
EMFAT
3
Emerald Mutual Fund Advisers Trust
Pennsylvania
$2.38M
4
VC
4
Vivo Capital
California
$28.7M
5
Invesco
5
Invesco
Georgia
$178K
Name Market Value Shares Shares
Change 		Shares
Change %
Walleye Trading
126
Walleye Trading
New York
– – – –
MP
127
Mangrove Partners
Connecticut
– – – –
CFGS
128
Concourse Financial Group Securities
Alabama
– – – –
HI
129
Harbour Investments
Wisconsin
$0 1 +1 New
2 3 4 5
6